Bio Protech Inc. (XKON:199290)
283.00
0.00 (0.00%)
At close: Jul 16, 2026
Bio Protech Market Cap
Bio Protech has a market cap or net worth of 4.09 billion as of July 21, 2026. Its market cap has decreased by -42.24% in one year.
Market Cap
4.09B
Enterprise Value
n/a
Revenue
20.58B
Ranking
n/a
PE Ratio
1.42
Stock Price
283.00
ChartMarket Cap Chart
Since April 5, 2017, Bio Protech's market cap has decreased from 7.43B to 4.09B, a decrease of -44.89%. That is a compound annual growth rate of -6.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 4.09B | -43.29% |
| Dec 29, 2025 | 7.22B | -16.83% |
| Dec 27, 2024 | 8.68B | -34.07% |
| Dec 28, 2023 | 13.16B | -15.35% |
| Dec 28, 2022 | 15.55B | 315.38% |
| Dec 30, 2021 | 3.74B | -54.00% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BIOBIJOU | 94.18B |
| Corentec | 53.63B |
| DENTIS CO.,Ltd | 40.00B |
| Genolution | 24.10B |
| Finemedix | 21.67B |
| Sanigen Co. | 15.58B |
| TASCOM | 14.85B |
| Alpha AI | 10.45B |